Advertisement

Boston Scientific Corp. (NYSE: BSX) of Natick said Thursday that the U.S. Food and Drug Administration has approved its Epic stent to open blocked arteries in patients with iliac artery stenosis.

SOURCE

Advertisement
Advertisement